Logo Logo
Switch Language to German
Polus, Stephanie; Pfadenhauer, Lisa Maria ORCID: 0000-0001-5038-8072; Brereton, Louise; Leppert, Wojciech; Wahlster, Philip; Gerhardus, Ansgar; Rehfuess, Eva Annette (2017): A consultation guide for assessing the applicability of health technologies: a case study. In: International Journal of Technology Assessment in Health Care: pp. 1-9
Full text not available from 'Open Access LMU'.


OBJECTIVES The translation of research findings into policy and practice is crucially dependent on the applicability of such findings in a given decision-making context. We explored in a case study whether a generic consultation guide to assess the applicability of a health technology could be rapidly deployed and deliver useful insights. METHODS A consultation guide based on the context and implementation for complex interventions (CICI) framework was developed and piloted to assess the applicability of reinforced home-based palliative care in three European countries. Individual consultations in England and Germany and a panel discussion in Poland were completed. RESULTS Various barriers may hinder successful implementation of reinforced home-based palliative care in the three countries. Whilst the experts across all countries emphasized the lack of funding along with organization and structure as major barriers, information varied by country for many of the other identified barriers and facilitators. Participants in the pilot study provided positive feedback in terms of understanding the topic and purpose of the consultation, and both individual and panel consultations could be easily implemented. CONCLUSIONS In this case study, the consultation guide presented a pragmatic, ready-to-use tool to assess the applicability of a health technology. As shown here, it can be used in a generic manner without discrete empirical information on the technology in question or, ideally, makes use of specific information collected as part of a HTA. Further studies are needed to validate this guide and apply it to other types of health technologies and more diverse decision-making contexts.